Screening for Albuminuria in Patients with Diabetes 2.0.1

This compact clinical tool provides healthcare professionals with a rapid and efficient method for assessing and managing albuminuria in patients with diabetes and other high-risk populations. Its design facilitates immediate, point-of-care decision-making, allowing for prompt intervention regardless of setting. The content is derived from the evidence-based clinical practice guidelines established by the Kidney Disease Outcomes Quality Initiative (KDOQI) and recommendations from the National Kidney Foundation.

Key Features:

• Enables quick evaluation of diabetic patients for albuminuria and chronic kidney disease (CKD).
• Supports evidence-based assessment and treatment strategies.
• Includes an interactive, customizable clinical action plan tailored to individual patient needs.

The tool is organized around essential educational topics:

• Understanding Albuminuria
• The importance of screening high-risk patients
• Optimal timing for screening
• Effective screening methods
• Follow-up procedures utilizing an interactive decision-making algorithm
• Key facts about albuminuria, diabetes, and CKD

Insights on Chronic Kidney Disease:

• Kidney disease is prevalent, serious, yet manageable when detected early.
• Approximately 26 million Americans are affected by kidney disease, with many unaware of their condition. Additional millions face increased risk.
• High-risk groups include individuals with diabetes, hypertension, or a family history of kidney disease. Ethnic groups such as African Americans, Hispanics, Asians, Pacific Islanders, Native Americans, and seniors are disproportionately affected.
• Early diagnosis can significantly slow disease progression.
• Advanced kidney failure necessitates dialysis or transplantation for survival.

The National Kidney Foundation leads efforts in the U.S. to improve awareness, prevention, and treatment of kidney disease. Its initiatives support healthcare professionals, patients, families, and at-risk populations nationwide.

Supporting this organization directly benefits those at risk and those living with CKD. For more information, visit www.kidney.org.

Address: 30 East 33rd Street, New York, NY 10016